Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)

BACKGROUND: 1. Compare SBRT +/− ADT for oligorecurrent-castration-sensitive PCa (OCS-PCa) in terms of efficacy, toxicity and Quality of Life (QoL). 2. Develop biology/imaging based prognostic tool that allows identifying OCS-PCa subclasses. METHODS: 1. Randomized clinical study (3 years for accrual...

Descripción completa

Detalles Bibliográficos
Autores principales: Marvaso, Giulia, Ciardo, Delia, Corrao, Giulia, Gandini, Sara, Fodor, Cristiana, Zerini, Dario, Rojas, Damaris Patricia, Augugliaro, Matteo, Bonizzi, Giuseppina, Pece, Salvatore, Cattani, Federica, Mazzocco, Ketti, Mistretta, Francesco Alessandro, Musi, Gennaro, Alessi, Sarah, Petralia, Giuseppe, Pravettoni, Gabriella, De Cobelli, Ottavio, Di Fiore, Pier Paolo, Viale, Giuseppe, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734417/
https://www.ncbi.nlm.nih.gov/pubmed/31500605
http://dx.doi.org/10.1186/s12885-019-6117-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734417/
https://www.ncbi.nlm.nih.gov/pubmed/31500605
http://dx.doi.org/10.1186/s12885-019-6117-z

Ejemplares similares